Targeting the progression of chronic kidney disease
Chronic kidney disease (CKD) is a devastating condition that is reaching epidemic levels
owing to the increasing prevalence of diabetes mellitus, hypertension and obesity, as well …
owing to the increasing prevalence of diabetes mellitus, hypertension and obesity, as well …
[HTML][HTML] Fibrosis in chronic kidney disease: pathogenesis and consequences
S Panizo, L Martínez-Arias, C Alonso-Montes… - International journal of …, 2021 - mdpi.com
Fibrosis is a process characterized by an excessive accumulation of the extracellular matrix
as a response to different types of tissue injuries, which leads to organ dysfunction. The …
as a response to different types of tissue injuries, which leads to organ dysfunction. The …
[HTML][HTML] Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis
Y Li, J Zhang, J Shi, K Liu, X Wang, Y Jia, T He… - Stem Cell Research & …, 2021 - Springer
Background Hypertrophic scar (HS) is a fibro-proliferative disorder of dermis after burn or
trauma and usually leads to esthetic disfiguration and functionary impairment for patients …
trauma and usually leads to esthetic disfiguration and functionary impairment for patients …
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
M Kato, R Natarajan - Nature Reviews Nephrology, 2019 - nature.com
The development and progression of diabetic kidney disease (DKD), a highly prevalent
complication of diabetes mellitus, are influenced by both genetic and environmental factors …
complication of diabetes mellitus, are influenced by both genetic and environmental factors …
[HTML][HTML] Renal tubule injury: a driving force toward chronic kidney disease
Renal tubules are the major component of the kidney and are vulnerable to a variety of
injuries including hypoxia, proteinuria, toxins, metabolic disorders, and senescence. It has …
injuries including hypoxia, proteinuria, toxins, metabolic disorders, and senescence. It has …
TGF-β: the master regulator of fibrosis
Transforming growth factor-β (TGF-β) is the primary factor that drives fibrosis in most, if not
all, forms of chronic kidney disease (CKD). Inhibition of the TGF-β isoform, TGF-β1, or its …
all, forms of chronic kidney disease (CKD). Inhibition of the TGF-β isoform, TGF-β1, or its …
[HTML][HTML] Smad3 signatures in renal inflammation and fibrosis
W Wu, X Wang, X Yu, HY Lan - International journal of biological …, 2022 - ncbi.nlm.nih.gov
Renal inflammation and fibrosis are key pathological features of acute kidney injury (AKI)
and chronic kidney disease (CKD). Smad3 is a critical mediator of TGF-β signaling and …
and chronic kidney disease (CKD). Smad3 is a critical mediator of TGF-β signaling and …
[HTML][HTML] TGF-beta as a master regulator of diabetic nephropathy
Diabetic nephropathy (DN) is one of the most common complications in diabetes mellitus
and the leading cause of end-stage renal disease. TGF-β is a pleiotropic cytokine and has …
and the leading cause of end-stage renal disease. TGF-β is a pleiotropic cytokine and has …
[HTML][HTML] Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment
L Chen, T Yang, DW Lu, H Zhao, YL Feng… - Biomedicine & …, 2018 - Elsevier
Chronic kidney disease (CKD) has emerged as a major cause of morbidity and mortality
worldwide. Interstitial fibrosis, glomerulosclerosis and inflammation play the central role in …
worldwide. Interstitial fibrosis, glomerulosclerosis and inflammation play the central role in …
[HTML][HTML] TGF-β/Smad signaling in renal fibrosis
TGF-β (transforming growth factor-β) is well identified as a central mediator in renal fibrosis.
TGF-β initiates canonical and non-canonical pathways to exert multiple biological effects …
TGF-β initiates canonical and non-canonical pathways to exert multiple biological effects …